MUFG Securities EMEA’s Evolent Health EVH Stock Holding History

MUFG Securities EMEA’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-124,877	Closed	-$1.57M	–	432
2019 Q1	$1.57M	Buy	+124,877	New	+$1.98M	0.02%	343

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

MUFG Securities EMEA's EVH Position: Q2 2019 in Review

MUFG Securities EMEA sold out of Evolent Health (EVH) in Q2 2019, closing a stake of 124,877 shares — an estimated $1.57M sold.

MUFG Securities EMEA first reported a position in EVH in Q1 2019 and held it in 1 quarter. The position peaked at $1.57M in Q1 2019. 183 funds tracked by Wall St. Rank hold EVH as of Q2 2019.

MUFG Securities EMEA reported no remaining Evolent Health position as of Q2 2019 after selling out during the quarter.
MUFG Securities EMEA sold 124,877 Evolent Health shares in Q2 2019, an estimated $1.57M.
MUFG Securities EMEA first reported a position in Evolent Health in Q1 2019 and held it in 1 quarter.
MUFG Securities EMEA's Evolent Health position peaked at $1.57M in Q1 2019.
183 funds tracked by Wall St. Rank held Evolent Health as of Q2 2019.

Based on MUFG Securities EMEA's 13F filing for Q2 2019, filed 13 Aug 2019.